TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $107,164,000 | -51.5% | 7,862,379 | -41.8% | 0.32% | -39.0% |
Q3 2021 | $221,157,000 | -15.2% | 13,501,650 | -12.9% | 0.53% | +9.5% |
Q2 2021 | $260,747,000 | -23.7% | 15,492,997 | -17.2% | 0.48% | -28.6% |
Q1 2021 | $341,775,000 | +117.9% | 18,717,144 | +117.2% | 0.68% | +62.8% |
Q4 2020 | $156,851,000 | +660.4% | 8,618,165 | +645.3% | 0.42% | +241.8% |
Q3 2020 | $20,628,000 | – | 1,156,297 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 7,931,116 | $140,381,000 | 32.92% |
Endurant Capital Management LP | 932,967 | $16,514,000 | 6.51% |
Glenview Capital Management | 26,430,828 | $467,826,000 | 4.24% |
Paulson & Co. | 13,244,711 | $234,431,000 | 3.98% |
Blackcrane Capital, LLC | 172,955 | $3,061,000 | 3.88% |
NINE MASTS CAPITAL Ltd | 1,474,286 | $26,146,000 | 3.74% |
Velanne Asset Management Ltd | 286,640 | $5,074,000 | 3.22% |
LMR Partners LLP | 4,563,591 | $80,884,000 | 2.95% |
SECTOR GAMMA AS | 796,299 | $14,094,000 | 2.26% |
MFN Partners Management, LP | 785,000 | $13,895,000 | 2.21% |